Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on anti-CD20 Disease Modifying Therapies

被引：0
|
作者：
Wolf, Andrew [1 ]
Pratt, Robert W. [1 ]
Crooks, Kristy [2 ,3 ]
Borko, Tyler [1 ]
Gonzalez, Jose Parra [1 ]
Vollmer, Timothy [1 ]
Frazer-Abel, Ashley [4 ,5 ]
机构：
[1] Univ Colorado, Dept Neurol, Aurora, CO USA
[2] Univ Colorado, Sch Med, Colorado Mol Correlates Lab CMOCO, Aurora, CO USA
[3] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA
[4] Univ Colorado, Sch Med, Exsera BioLabs, Aurora, CO USA
[5] Univ Colorado, Sch Med, Dept Med, Div Rheumatol, Aurora, CO USA
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
340
引用
收藏
页码：S179 / S180
页数：2
相关论文
共 50 条
  • [1] Anti-CD20 disease modifying therapies decrease the humoral response to COVID-19 mRNA vaccination in patients with multiple sclerosis
    Wolf, A.
    Pratt, R.
    Crooks, K.
    Borko, T.
    Gonzalez, J. Parra
    Vollmer, T.
    Frazer-Abel, A.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 581 - 581
  • [2] COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
    Meca-Lallana, Virginia
    Aguirre, Clara
    Rio, Beatrizdel
    Cardenoso, Laura
    Alarcon, Teresa
    Vivancos, Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [3] Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [4] The immune response to Covid-19 mRNA vaccination among Lymphoma patients receiving anti-CD20 treatment
    Komlodi-Pasztor, Edina
    Escarra-Senmarti, Marta
    Bazer, Danielle A.
    Bhatnagar, Aastha
    Perez Heydrich, Carlos A.
    Messmer, Marcus
    Ambinder, Richard F.
    Gladstone, Douglas E.
    Clayton, Laura
    Goodrich, Amy
    Schoch, Laura
    Wagner-Johnston, Nina
    VandenBussche, Christopher J.
    Huang, Peng
    Holdhoff, Matthias
    Rosario, Maximillian
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Comparison of anti-CD20 therapies versus other disease modifying therapies on postpartum disease activity in patients with multiple sclerosis
    Passeri, M.
    Alvarez, E.
    Shah, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 462 - 462
  • [6] Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [7] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [8] Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination
    Orru, Valeria
    Serra, Valentina
    Marongiu, Michele
    Lai, Sandra
    Lodde, Valeria
    Zoledziewska, Magdalena
    Steri, Maristella
    Loizedda, Annalisa
    Lobina, Monia
    Piras, Maria Grazia
    Virdis, Francesca
    Delogu, Giuseppe
    Marini, Maria Giuseppina
    Mingoia, Maura
    Floris, Matteo
    Masala, Marco
    Castelli, M. Paola
    Mostallino, Rafaela
    Frau, Jessica
    Lorefice, Lorena
    Farina, Gabriele
    Fronza, Marzia
    Carmagnini, Daniele
    Carta, Elisa
    Pilotto, Silvy
    Chessa, Paola
    Devoto, Marcella
    Castiglia, Paolo
    Solla, Paolo
    Zarbo, Roberto Ignazio
    Idda, Maria Laura
    Pitzalis, Maristella
    Cocco, Eleonora
    Fiorillo, Edoardo
    Cucca, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
    Wu, Xi
    Wang, Lu
    Shen, Lu
    Tang, Kefu
    EBIOMEDICINE, 2022, 81
  • [10] COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issues
    Chirap-Mitulschi, Ioan-Alexandru
    Ghimus, Constantin
    Chirap-Mitulschi, Andreea Raluca
    Antoniu, Sabina Antonela
    Dragomir, Raluca
    DRUGS OF TODAY, 2022, 58 (12) : 605 - 620
12345